Indian Share of the Clinical Trial Market

Contract Research Organizations, and the outsourcing of clinical trials, from markets outside the U.S. has proved to be a booming industry. India, especially has seen the effects of this increase in industry size. As reported here in in-Pharma Technologist.com, it is expected that by 2011 India will hold a 15% share of the market. In 2007 it was reported that the Indian CRO industry was valued at $200 million, however, by 2010 that value is expected to increase to $500 to $600 million. Data from KPMG indicates that the reason for this boom is that it is considered to be the cheapest market for clinical trials along side Russia.